Literature DB >> 3549778

Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis.

R C May, R A Kelly, W E Mitch.   

Abstract

Chronic renal failure (CRF) is associated with metabolic acidosis and abnormal muscle protein metabolism. As we have shown that acidosis by itself stimulates muscle protein degradation by a glucocorticoid-dependent mechanism, we assessed the contribution of acidosis to changes in muscle protein turnover in CRF. A stable model of uremia was achieved in partially nephrectomized rats (plasma urea nitrogen, 100-120 mg/dl, blood bicarbonate less than 21 meq/liter). CRF rats excreted 22% more nitrogen than pair-fed controls (P less than 0.005), so muscle protein synthesis and degradation were measured in perfused hindquarters. CRF rats had a 90% increase in net protein degradation (P less than 0.001); this was corrected by dietary bicarbonate. Correction of acidosis did not reduce the elevated corticosterone excretion rate of CRF rats, nor did it improve a second defect in muscle protein turnover, a 34% lower rate of insulin-stimulated protein synthesis. Thus, abnormal nitrogen production in CRF is due to accelerated muscle proteolysis caused by acidosis and an acidosis-independent inhibition of insulin-stimulated muscle protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549778      PMCID: PMC424289          DOI: 10.1172/JCI112924

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Effect of protein intake on weight gain and plasma amino acid levels in uremic rats.

Authors:  M Wang; I Vyhmeister; J D Kopple; M E Swendseid
Journal:  Am J Physiol       Date:  1976-05

2.  Body composition in chronic renal failure.

Authors:  G A Coles
Journal:  Q J Med       Date:  1972-01

3.  Mode of killing and plasma corticosterone concentrations in the rat.

Authors:  J A Carney; B L Walker
Journal:  Lab Anim Sci       Date:  1973-10

4.  Hindlimb muscle fiber populations of five mammals.

Authors:  M A Ariano; R B Armstrong; V R Edgerton
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

5.  Fluorimetric measurement of the phenylalanine content of human granulocytes.

Authors:  T M Andrews; R Goldthorp; R W Watts
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

6.  Effect of uremia on nutritionally-induced variations in protein metabolism.

Authors:  M A Holliday; C Chantler; R MacDonnell; J Keitges
Journal:  Kidney Int       Date:  1977-04       Impact factor: 10.612

7.  Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus.

Authors:  L S Jefferson; J B Li; S R Rannels
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

8.  Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism.

Authors:  N B Ruderman; C R Houghton; R Hems
Journal:  Biochem J       Date:  1971-09       Impact factor: 3.857

9.  Specific defects in insulin-mediated muscle metabolism in acute uremia.

Authors:  R C May; A S Clark; M A Goheer; W E Mitch
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

10.  Hyperglucagonemia of renal failure.

Authors:  G L Bilbrey; G R Faloona; M G White; J P Knochel
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  57 in total

Review 1.  Mechanisms accelerating muscle atrophy in catabolic diseases.

Authors:  W E Mitch
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 3.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

4.  Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.

Authors:  Liping Zhang; Vik Rajan; Eugene Lin; Zhaoyong Hu; H Q Han; Xiaolan Zhou; Yanping Song; Hosung Min; Xiaonan Wang; Jie Du; William E Mitch
Journal:  FASEB J       Date:  2011-01-31       Impact factor: 5.191

5.  Anion gap predicts early mortality after starting hemodialysis in the elderly.

Authors:  Yohei Arai; Hiroyuki Tanaka; Shingo Shioji; Emi Sakamoto; Isao Kondo; Minami Suzuki; Daisuke Katagiri; Manami Tada; Fumihiko Hinoshita
Journal:  Clin Exp Nephrol       Date:  2020-01-27       Impact factor: 2.801

6.  Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription.

Authors:  S R Price; J L Bailey; X Wang; C Jurkovitz; B K England; X Ding; L S Phillips; W E Mitch
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 7.  Dietary acid load: a novel nutritional target in chronic kidney disease?

Authors:  Julia J Scialla; Cheryl A M Anderson
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

8.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes.

Authors:  W E Mitch; R Medina; S Grieber; R C May; B K England; S R Price; J L Bailey; A L Goldberg
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.

Authors:  Liping Zhang; Xiaonan H Wang; Huiling Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.